trending Market Intelligence /marketintelligence/en/news-insights/trending/efbcu1dzFubSiXaCPC7jhg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Castlight Health maintains FY'17 outlook

Banking Essentials Newsletter December Edition Part 2

Banking Essentials Newsletter - November Edition

Online Brokerage Space Should Remain Rich Source Of M&A

Street Talk Episode 70 - Banks' Liquidity Conundrum Could Fuel M&A Activity


Castlight Health maintains FY'17 outlook

Castlight Health Inc. continues to expect to record a non-GAAP net loss per share for the full year of 24 cents to 28 cents.

The S&P Capital IQ consensus normalized estimate for the year calls for a loss of 26 cents per share.

The company also maintained its guidance for a non-GAAP operating loss of $31 million to $35 million and GAAP revenue of $132 million to $136 million.

For the second quarter, Castlight Health reported a net loss of $13.7 million, or 11 cents per share, compared with a net loss of $16.7 million, or 17 cents per share, in the year-ago period.

The second-quarter non-GAAP net loss was $9.8 million, or 7 cents per share, compared with a loss of $5.3 million, or 5 cents per share, in the second quarter of 2016.

The S&P Capital IQ consensus normalized estimate for the quarter called for a loss of 9 cents per share